DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 84 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Vineet Laboratories Limited — Outcome of Board Meeting

NSE 25 Aug·25 Aug 2026, 2:22 pm

Vineet Laboratories

Vineet Laboratories Limited has informed the stock exchange that its board has approved the financial results for the period ending March 31, 2026. The company has submitted these documents to comply with regulatory disclosure norms, ensuring transparency for the market.

This disclosure is a routine procedural update that allows investors to access the company's performance data. While the specific figures have not yet been released, this announcement signals that the financial statements are finalized and ready for review.

Investors should look out for the detailed financial report to understand the company's revenue growth, profit margins, and cash flow position. This information will be crucial for assessing the company's current financial health and future prospects.